Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hamilton

Showing results (1031-1040 of 1,112) with videos related to

Pageof 112
Sort By:
Spine|August 4, 2025
Self-Image in Adult Spinal Deformity: The Critical Link Between Baseline Disability, Treatment Choice, and Surgical SatisfactionShay Bess, Breton G Line, Peter G Passias, et al.
Spine|September 26, 2025
PROMIS CAT Outperforms Legacy Measures and Demonstrates Patient Health Domain Normalization at Minimum Two-Year Follow-Up After Adult Spine Deformity SurgeryShay Bess, Breton G Line, Virginie Lafage, et al.
The Journal of Infectious Diseases|July 27, 2022
Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19Selin Somersan-Karakaya, Eleftherios Mylonakis, Vidya P Menon, et al.
The Lancet. Infectious Diseases|July 8, 2022
Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trialGary A Herman, Meagan P O'Brien, Eduardo Forleo-Neto, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|October 23, 2024
Defining modern iatrogenic flatback syndrome: examination of segmental lordosis in short lumbar fusion patients undergoing thoracolumbar deformity correctionBassel G Diebo, Manjot Singh, Mariah Balmaceno-Criss, et al.
The Lancet. Infectious Diseases|September 5, 2024
Effect of timing of casirivimab and imdevimab administration relative to mRNA-1273 COVID-19 vaccination on vaccine-induced SARS-CoV-2 neutralising antibody responses: a prospective, open-label, phase 2, randomised controlled trialFlonza Isa, Ana M Gonzalez Ortiz, Jonathan Meyer, et al.
The New England Journal of Medicine|September 29, 2021
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19David M Weinreich, Sumathi Sivapalasingam, Thomas Norton, et al.
Science Translational Medicine|November 6, 2024
Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infectionChristopher D Petro, Andrea T Hooper, Avery Peace, et al.
Cell|June 23, 2021
The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studiesRichard Copin, Alina Baum, Elzbieta Wloga, et al.
The New England Journal of Medicine|August 4, 2021
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19Meagan P O'Brien, Eduardo Forleo-Neto, Bret J Musser, et al.
Pageof 112

Showing results (1031-1040 of 1,112) with videos related to

Sort By:
Pageof 112
Spine|August 4, 2025
Self-Image in Adult Spinal Deformity: The Critical Link Between Baseline Disability, Treatment Choice, and Surgical SatisfactionShay Bess, Breton G Line, Peter G Passias, et al.
Spine|September 26, 2025
PROMIS CAT Outperforms Legacy Measures and Demonstrates Patient Health Domain Normalization at Minimum Two-Year Follow-Up After Adult Spine Deformity SurgeryShay Bess, Breton G Line, Virginie Lafage, et al.
The Journal of Infectious Diseases|July 27, 2022
Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19Selin Somersan-Karakaya, Eleftherios Mylonakis, Vidya P Menon, et al.
The Lancet. Infectious Diseases|July 8, 2022
Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trialGary A Herman, Meagan P O'Brien, Eduardo Forleo-Neto, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|October 23, 2024
Defining modern iatrogenic flatback syndrome: examination of segmental lordosis in short lumbar fusion patients undergoing thoracolumbar deformity correctionBassel G Diebo, Manjot Singh, Mariah Balmaceno-Criss, et al.
The Lancet. Infectious Diseases|September 5, 2024
Effect of timing of casirivimab and imdevimab administration relative to mRNA-1273 COVID-19 vaccination on vaccine-induced SARS-CoV-2 neutralising antibody responses: a prospective, open-label, phase 2, randomised controlled trialFlonza Isa, Ana M Gonzalez Ortiz, Jonathan Meyer, et al.
The New England Journal of Medicine|September 29, 2021
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19David M Weinreich, Sumathi Sivapalasingam, Thomas Norton, et al.
Science Translational Medicine|November 6, 2024
Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infectionChristopher D Petro, Andrea T Hooper, Avery Peace, et al.
Cell|June 23, 2021
The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studiesRichard Copin, Alina Baum, Elzbieta Wloga, et al.
The New England Journal of Medicine|August 4, 2021
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19Meagan P O'Brien, Eduardo Forleo-Neto, Bret J Musser, et al.
Pageof 112